PROCESS FOR PREPARING ACYCLIC HCV PROTEASE INHIBITORS

摘要

Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection. The disclosed processes use SNAr-type coupling reactions between peptidic compounds having a hydroxyproline moiety and halogenated or sulfonated bromoquinoline compounds.